{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T07:56:05Z","timestamp":1766735765191,"version":"3.48.0"},"reference-count":19,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T00:00:00Z","timestamp":1766707200000},"content-version":"vor","delay-in-days":25,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,24]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Acute promyelocytic leukemia (APL) is a subtype of acute myeloid leukemia (AML); it has a high response rate and long-term survival with differentiation therapy and chemotherapy. However, only one previous case of APL with double minute chromosomes (DMs, a poor prognostic factor for AML) has been reported. We report the case of a patient with APL and DMs. A 44-year-old woman was treated with all-trans retinoic acid (ATRA) and chemotherapy and achieved molecular complete remission (mCR). However, the condition relapsed after 15\u00a0months. She was treated with arsenic trioxide and autologous transplantation and experienced mCR. Her peripheral blood was positive for minimal residual disease (MRD) 2\u00a0months after autologous transplantation. She became MRD-negative with ATRA and has maintained the negative status for 15\u00a0months. This is the first report to suggest that patients with APL and DMs may be a high-risk group for relapse and benefit from maintaining with ATRA.<\/jats:p>","DOI":"10.1093\/omcr\/omaf259","type":"journal-article","created":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T12:47:15Z","timestamp":1761655635000},"source":"Crossref","is-referenced-by-count":0,"title":["Acute Promyelocytic Leukemia with double minute chromosomes: a rare case with high relapse risk"],"prefix":"10.1093","volume":"2025","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-4215-2094","authenticated-orcid":false,"given":"Yohei","family":"Sasaki","sequence":"first","affiliation":[{"name":"Division of Hematology, Department of Medicine, Showa Medical University School of Medicine , 1-5-8 Hatanodai, Shinagawa-Ku, Tokyo 142-8666 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shotaro","family":"Shimada","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Medicine, Showa Medical University School of Medicine , 1-5-8 Hatanodai, Shinagawa-Ku, Tokyo 142-8666 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natsuki","family":"Kawamata","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Medicine, Showa Medical University School of Medicine , 1-5-8 Hatanodai, Shinagawa-Ku, Tokyo 142-8666 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidenori","family":"Hayashi","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Medicine, Showa Medical University School of Medicine , 1-5-8 Hatanodai, Shinagawa-Ku, Tokyo 142-8666 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuki","family":"Nagao","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Medicine, Showa Medical University School of Medicine , 1-5-8 Hatanodai, Shinagawa-Ku, Tokyo 142-8666 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai","family":"Kuroiwa","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Medicine, Showa Medical University School of Medicine , 1-5-8 Hatanodai, Shinagawa-Ku, Tokyo 142-8666 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hinako","family":"Narita","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Medicine, Showa Medical University School of Medicine , 1-5-8 Hatanodai, Shinagawa-Ku, Tokyo 142-8666 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reiko","family":"Okamura","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Medicine, Showa Medical University School of Medicine , 1-5-8 Hatanodai, Shinagawa-Ku, Tokyo 142-8666 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Megumi","family":"Watanuki","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Medicine, Showa Medical University School of Medicine , 1-5-8 Hatanodai, Shinagawa-Ku, Tokyo 142-8666 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nana","family":"Arai","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Medicine, Showa Medical University School of Medicine , 1-5-8 Hatanodai, Shinagawa-Ku, Tokyo 142-8666 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kouji","family":"Yanagisawa","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Medicine, Showa Medical University School of Medicine , 1-5-8 Hatanodai, Shinagawa-Ku, Tokyo 142-8666 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norimichi","family":"Hattori","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Medicine, Showa Medical University School of Medicine , 1-5-8 Hatanodai, Shinagawa-Ku, Tokyo 142-8666 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,12,26]]},"reference":[{"key":"2025122602495586000_ref1","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/j.rcl.2011.05.004","article-title":"Leukemia and lymphoma","volume":"49","author":"Guillerman","year":"2011","journal-title":"Radiol Clin North Am"},{"key":"2025122602495586000_ref2","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1097\/MNM.0000000000001846","article-title":"PET\/CT in leukemia: utility and future directions","volume":"45","author":"Al-Ibraheem","year":"2024","journal-title":"Nucl Med Commun"},{"key":"2025122602495586000_ref3","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1016\/S1470-2045(15)00193-X","article-title":"Arsenic trioxide and all-trans retinoic acid treatment for acute promyelocytic leukaemia in all risk groups (AML17): results of a randomised, controlled, phase 3 trial","volume":"16","author":"Burnett","year":"2015","journal-title":"Lancet Oncol"},{"key":"2025122602495586000_ref4","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1007\/s12185-023-03696-7","article-title":"Risk factors and remaining challenges in the treatment of acute promyelocytic leukemia","volume":"120","author":"Yokoyama","year":"2024","journal-title":"Int J Hematol"},{"key":"2025122602495586000_ref5","doi-asserted-by":"publisher","first-page":"3095","DOI":"10.1182\/blood-2012-11-466862","article-title":"Phase 2 study of arsenic trioxide followed by autologous hematopoietic cell transplantation for relapsed acute promyelocytic leukemia","volume":"121","author":"Yanada","year":"2013","journal-title":"Blood"},{"key":"2025122602495586000_ref6","first-page":"1247","article-title":"Definition of relapse risk and role of nonanthracycline drugs for consolidation in patients with acute promyelocytic leukemia: a joint study of the PETHEMA and GIMEMA cooperative groups","volume":"96","author":"Sanz","year":"2000","journal-title":"Blood"},{"key":"2025122602495586000_ref7","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.3390\/cancers12061444","article-title":"Impact of CD56 continuously recognizable as prognostic value of acute promyelocytic leukemia: results of multivariate analyses in the Japan adult Leukemia study group (JALSG)-APL204 study and a review of the literature","volume":"12","author":"Takeshita","year":"2020","journal-title":"Cancers"},{"key":"2025122602495586000_ref8","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1002\/ajh.25573","article-title":"Mutational landscape of patients with acute promyelocytic leukemia at diagnosis and relapse","volume":"94","author":"Iaccarino","year":"2019","journal-title":"Am J Hematol"},{"key":"2025122602495586000_ref9","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1046\/j.1365-2141.2000.02442.x","article-title":"Additional chromosomal abnormalities in patients with acute promyelocytic leukaemia (APL) do not confer poor prognosis: results of APL 93 trial","volume":"111","author":"De Botton","year":"2000","journal-title":"Br J Haematol"},{"key":"2025122602495586000_ref10","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.cancergen.2016.05.072","article-title":"Double minute chromosomes in acute myeloid leukemia, myelodysplastic syndromes, and chronic myelomonocytic leukemia are associated with micronuclei, MYC or MLL amplification, and complex karyotype","volume":"209","author":"Huh","year":"2016","journal-title":"Cancer Genet"},{"key":"2025122602495586000_ref11","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1002\/ajh.20151","article-title":"Double minute chromosomes in monoblastic (M5) and myeloblastic (M2) acute myeloid leukemia: two case reports and a review of literature","volume":"77","author":"Thomas","year":"2004","journal-title":"Am J Hematol"},{"key":"2025122602495586000_ref12","doi-asserted-by":"publisher","first-page":"2466","DOI":"10.1080\/10428194.2021.1919663","article-title":"Double minute chromosomes in acute myeloid leukemia and myelodysplastic syndromes are associated with complex karyotype, monosomal karyotype, TP53 deletion, and TP53 mutations","volume":"62","author":"Wang","year":"2021","journal-title":"Leuk Lymphoma"},{"key":"2025122602495586000_ref13","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.cancergencyto.2009.12.011","article-title":"Rapid response to induction in a case of acute promyelocytic leukemia with MYC amplification on double minutes at diagnosis","volume":"198","author":"Zuberi","year":"2010","journal-title":"Cancer Genet Cytogenet"},{"key":"2025122602495586000_ref14","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.cancergencyto.2009.11.001","article-title":"Concomitant and successive amplifications of MYC in APL-like leukemia","volume":"197","author":"Bruy\u00e8re","year":"2010","journal-title":"Cancer Genet Cytogenet"},{"key":"2025122602495586000_ref15","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s13039-014-0067-6","article-title":"Genomic amplification of MYC as double minutes in a patient with APL-like leukemia","volume":"7","author":"Poddighe","year":"2014","journal-title":"Mol Cytogenet"},{"key":"2025122602495586000_ref16","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.cancergen.2025.02.005","article-title":"Complex genetic structural aberrations revealed by optical genome mapping in a case of APL-like morphology","volume":"292-293","author":"Sathyanarayana","year":"2025","journal-title":"Cancer Genet"},{"key":"2025122602495586000_ref17","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1182\/blood-2009-07-233387","article-title":"Very long-term outcome of acute promyelocytic leukemia after treatment with all-trans retinoic acid and chemotherapy: the European APL Group experience","volume":"115","author":"Ad\u00e8s","year":"2010","journal-title":"Blood"},{"key":"2025122602495586000_ref18","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/s0165-4608(99)00015-1","article-title":"Terminal deletion of the long arm of chromosome 9 in acute promyelocytic leukemia with a cryptic PML\/RAR alpha rearrangement","volume":"113","author":"Yamamoto","year":"1999","journal-title":"Cancer Genet Cytogenet"},{"key":"2025122602495586000_ref19","doi-asserted-by":"publisher","first-page":"3413","DOI":"10.1182\/blood-2011-11-393264","article-title":"Role of minimal residual disease monitoring in acute promyelocytic leukemia treated with arsenic trioxide in frontline therapy","volume":"119","author":"Chendamarai","year":"2012","journal-title":"Blood"}],"container-title":["Oxford Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/omcr\/article-pdf\/2025\/12\/omaf259\/66128276\/omaf259.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/omcr\/article-pdf\/2025\/12\/omaf259\/66128276\/omaf259.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T07:50:05Z","timestamp":1766735405000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/omcr\/article\/doi\/10.1093\/omcr\/omaf259\/8404886"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":19,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12,24]]}},"URL":"https:\/\/doi.org\/10.1093\/omcr\/omaf259","relation":{},"ISSN":["2053-8855"],"issn-type":[{"type":"electronic","value":"2053-8855"}],"subject":[],"published-other":{"date-parts":[[2025,12]]},"published":{"date-parts":[[2025,12]]},"article-number":"omaf259"}}